Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-115339
Filing Date
2012-03-15
Accepted
2012-03-14 18:37:13
Documents
16
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d313870d10k.htm 10-K 1263854
2 EX-3.1 d313870dex31.htm EX-3.1 42838
3 EX-3.2 d313870dex32.htm EX-3.2 135517
4 EX-23.1 d313870dex231.htm EX-23.1 1446
5 EX-31.1 d313870dex311.htm EX-31.1 8315
6 EX-31.2 d313870dex312.htm EX-31.2 8297
7 EX-32.1 d313870dex321.htm EX-32.1 3805
8 EX-32.2 d313870dex322.htm EX-32.2 2655
9 GRAPHIC g313870g94s92.jpg GRAPHIC 50750
10 GRAPHIC g313870g99b05.jpg GRAPHIC 148964
11 GRAPHIC g313870p62.gif GRAPHIC 7059
12 GRAPHIC g313870p63.gif GRAPHIC 7357
13 GRAPHIC g313870p64.gif GRAPHIC 16382
14 GRAPHIC g313870p66.gif GRAPHIC 10151
15 GRAPHIC g313870p67.gif GRAPHIC 10262
16 GRAPHIC g313870p68.gif GRAPHIC 16520
  Complete submission text file 0001193125-12-115339.txt   1837386
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 12691525
SIC: 2834 Pharmaceutical Preparations